The Bioequivalence Study of Alfuzosin 10 mg Prolong-released Tablets Under Fed Conditions
Status:
NOT_YET_RECRUITING
Trial end date:
2024-03-21
Target enrollment:
Participant gender:
Summary
Objective:
Primary objective of the present study was to assess the relative bioavailability of Alfuzosin 10 mg Prolong-released Tablets under Fed conditions, in Healthy Thai Male Volunteers after an oral administration with 7 days washout period.
Study Design:
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study